Physician profile
Michael Metro
NPI 1154308872
$93,146.14
in general payments reported to CMS, 2019-2025
17 companies · $5,110 in 2025
The $5,110 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $14K · 2021: $22K · 2022: $18K · 2023: $4,963 · 2024: $5,359 · 2025: $5,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $2,116 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,925.00 |
| Food and Beverage | $2,116.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $390.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $67,555.04 | 2019-2024 | Xiaflex |
| Boston Scientific Corporation | $17,650.41 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Ams 800 Artificial Urinary Sphincter |
| Endo USA, INC. | $6,425.00 | 2024-2025 | Xiaflex |
| Coloplast Corp | $629.11 | 2019-2024 | Titan, Speedicath |
| Stryker Corporation | $165.20 | 2021 | |
| Urovant Sciences INC | $135.38 | 2022 | |
| Astellas Pharma US INC | $113.31 | 2022-2025 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $86.02 | 2024-2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $85.91 | 2021 | |
| Urogen Pharma, INC. | $56.36 | 2021-2025 | |
| Calyxo, INC. | $47.50 | 2025 | Cvac Aspiration System |
| Innovation Technologies INC | $44.11 | 2022 | |
| Teleflex LLC | $43.46 | 2021-2023 | Urolift |
| Convatec INC. | $43.24 | 2025 | |
| 180 Medical, INC. | $28.00 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $26.17 | 2025 | Erleada |
| Allergan, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Metro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.